Literature DB >> 15210062

Effect of simvastatin on endothelium-dependent vaso-relaxation and endogenous nitric oxide synthase inhibitor.

Jun-lin Jiang1, De-jian Jiang, Yu-hai Tang, Nian-sheng Li, Han-wu Deng, Yuan-jian Li.   

Abstract

AIM: To investigate the effect of simvastatin on endothelium-dependent vasorelaxation and endogenous nitric oxide synthesis inhibitor asymmetric dimethylarginine (ADMA) in rats and cultured ECV304 cells.
METHODS: Endothelial injury was induced by a single injection of low density lipoprotein (LDL) (4 mg/kg, 48 h) in rats or incubation with LDL (300 mg/L) or oxidative-modified LDL (100 mg/L) in cultured ECV304 cells, and vasodilator responses to acetylcholine (ACh) in the aortic rings and the level of ADMA, nitrite/nitrate (NO) and tumor necrosis factor-alpha (TNF-alpha) in the serum or cultured medium were determined. And the adhesion of the monocytes to endothelial cells and the activity of dimethylarginine dimethylaminohydrolase (DDAH) in the cultured ECV304 cells were measured.
RESULTS: A single injection of LDL decreased endothelium-dependent relaxation to ACh, markedly increased the serum level of endogenous ADMA and TNF-alpha, and reduced serum level of NO. Pretreatment with simvastatin (30 or 60 mg/kg) markedly attenuated inhibition of vasodilator responses to ACh, the increased level of TNF-alpha and the decreased level of NO by LDL, but no effect on serum concentration of endogenous ADMA. In cultured ECV304 cells, LDL or ox-LDL markedly increased the level of ADMA and TNF-alpha and potentiated the adhesion of monocytes to endothelial cells, concomitantly with a significantly decrease in the activity of DDAH and serum level of NO. Pretreatment with simvastatin (0.1, 0.5, or 2.5 micromol/L) markedly decreased the level of TNF-alpha and the adhesion of monocytes to endothelial cells, but did not affect the concentration of endogenous ADMA and the activity of DDAH.
CONCLUSION: Simvastatin protect the vascular endothelium against the damages induced by LDL or ox-LDL in rats or cultured ECV304 cells, and the beneficial effects of simvastatin may be related to the reduction of inflammatory cytokine TNF-alpha level.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15210062

Source DB:  PubMed          Journal:  Acta Pharmacol Sin        ISSN: 1671-4083            Impact factor:   6.150


  8 in total

1.  Fenofibrate decreases asymmetric dimethylarginine level in cultured endothelial cells by inhibiting NF-kappaB activity.

Authors:  Tian-Lun Yang; Mei-Fang Chen; Bai-Lin Luo; Qi-Ying Xie; Jun-Lin Jiang; Yuan-Jian Li
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2005-05-25       Impact factor: 3.000

2.  Mechanisms of simvastatin-induced vasodilatation of rat superior mesenteric arteries.

Authors:  Yulong Chen; Hongmei Zhang; Huanhuan Liu; Ailan Cao
Journal:  Biomed Rep       Date:  2016-09-12

3.  Protective Effects of Simvastatin Against Alendronate-Induced Gastric Mucosal Injury in Rats.

Authors:  Nathalia S Carvalho; Mônica M Silva; Renan O Silva; Lucas A D Nicolau; Thiago S L Araújo; Douglas S Costa; Nayara A Sousa; Luan K M Souza; Pedro M G Soares; Jand Venes R Medeiros
Journal:  Dig Dis Sci       Date:  2015-09-24       Impact factor: 3.199

4.  Plasma adhesion and inflammation markers: asymmetrical dimethyl-L-arginine and secretory phospholipase A2 concentrations before and after laparoscopic gastric banding in morbidly obese patients.

Authors:  Dildar Konukoglu; Hafize Uzun; Sinem Firtina; Pinar Cigdem Arica; Ahmet Kocael; Mustafa Taskin
Journal:  Obes Surg       Date:  2007-05       Impact factor: 4.129

Review 5.  Update on statin-mediated anti-inflammatory activities in atherosclerosis.

Authors:  Fabrizio Montecucco; François Mach
Journal:  Semin Immunopathol       Date:  2009-05-05       Impact factor: 9.623

Review 6.  Role of the eNOS Uncoupling and the Nitric Oxide Metabolic Pathway in the Pathogenesis of Autoimmune Rheumatic Diseases.

Authors:  Anna Łuczak; Marta Madej; Agata Kasprzyk; Adrian Doroszko
Journal:  Oxid Med Cell Longev       Date:  2020-04-13       Impact factor: 6.543

7.  Metabolite Signature of Simvastatin Treatment Involves Multiple Metabolic Pathways.

Authors:  Lilian Fernandes Silva; Rowmika Ravi; Jagadish Vangipurapu; Markku Laakso
Journal:  Metabolites       Date:  2022-08-16

Review 8.  Asymmetric dimethylarginine (ADMA) and endothelial dysfunction: implications for atherogenesis.

Authors:  Maurício Batista Paes Landim; Antônio Casella Filho; Antônio Carlos Palandri Chagas
Journal:  Clinics (Sao Paulo)       Date:  2009-05       Impact factor: 2.365

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.